First participant vaccinated in study of ovx836 booster dose

Therapy shows high efficacy in initial trial phase

First patient dosed in phase 1b trial of MB310 therapy

New long-term partnership to address neurological disorder treatments

Eco-friendly inhalers aim to reduce environmental impact

Insight into double-blind, phase i/ii clinical trial for oesophageal cancer

New treatment option approved for women in Scotland

First car t-cell therapy accepted for second-line treatment in Scotland